title: Skin testing and hypersensitivity reactions to oxaliplatin.
authors.forename: C
authors.initials: C
authors.lastname: Garufi
authors.forename: A
authors.initials: A
authors.lastname: Cristaudo
authors.forename: B
authors.initials: B
authors.lastname: Vanni
authors.forename: E
authors.initials: E
authors.lastname: Bria
authors.forename: A M
authors.initials: AM
authors.lastname: Aschelter
authors.forename: B
authors.initials: B
authors.lastname: Santucci
authors.forename: E
authors.initials: E
authors.lastname: Terzoli
mesh_terms: D000970:Antineoplastic Agents / Q000009:adverse effects* / Q000276:immunology; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use; D015179:Colorectal Neoplasms / Q000188:drug therapy*; D004342:Drug Hypersensitivity / Q000175:diagnosis*; D005260:Female; D005472:Fluorouracil / Q000008:administration & dosage; D005492:Folic Acid / Q000008:administration & dosage; D006801:Humans; D007271:Injections, Intradermal; D008297:Male; D008875:Middle Aged; D009944:Organoplatinum Compounds / Q000008:administration & dosage / Q000009:adverse effects* / Q000627:therapeutic use; D000077150:Oxaliplatin; D011237:Predictive Value of Tests; D012882:Skin Tests
chemical_list: D000970:Antineoplastic Agents; D009944:Organoplatinum Compounds; D000077150:Oxaliplatin; D005492:Folic Acid; D005472:Fluorouracil